Volume | 4,574,041 |
|
|||||
News | - | ||||||
Day High | 0.0516 | Low High |
|||||
Day Low | 0.0483 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
SiNtx Technologies Inc | SINT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0516 | 0.0483 | 0.0516 | 0.0505 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,196 | 4,574,041 | $ 0.0494214 | $ 226,056 | - | 0.0434 - 2.4461 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
10:55:30 | 500 | $ 0.0506 | USD |
SiNtx Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
212.99k | 4.26M | - | 1.56M | -16.49M | -3.87 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
SiNtx Technologies News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SINT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.143 | 0.1481 | 0.0434 | 0.0540346 | 17,394,642 | -0.0924 | -64.62% |
1 Month | 0.137 | 0.1481 | 0.0434 | 0.0636071 | 4,953,533 | -0.0864 | -63.07% |
3 Months | 0.3901 | 0.426 | 0.0434 | 0.1229812 | 3,816,346 | -0.3395 | -87.03% |
6 Months | 0.774 | 0.90 | 0.0434 | 0.1530146 | 1,951,567 | -0.7234 | -93.46% |
1 Year | 2.37 | 2.4461 | 0.0434 | 0.2290435 | 1,034,883 | -2.32 | -97.86% |
3 Years | 184.00 | 205.50 | 0.0434 | 34.22 | 1,178,579 | -183.95 | -99.97% |
5 Years | 20.00 | 550.00 | 0.0434 | 121.01 | 1,964,411 | -19.95 | -99.75% |
SiNtx Technologies Description
SINTX Technologies Inc is a commercial biomaterial company engaged in using its silicon nitride technology platform to develop, manufacture, and sell a range of medical devices. The company derives product revenue primarily from the manufacture and sale of spinal fusion products used in the treatment of spine disorders. It produces silicon nitride for use in commercial products and product candidates in the forms of Solid Silicon Nitride, Porous Silicon Nitride, and Silicon Nitride Powder, among others. It is also engaged in developing wear-and corrosion-resistant implant components for hip and knee arthroplasty. |